Arich Enterprise Co (ROCO:4173) 5-Year Yield-on-Cost %: 12.52 (As of Aug. 14, 2026) — 102% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4173 Arich Enterprise Co Ltd ROCO:4173
67 GF Score
Price NT$17.25
GF Value NT$29.18
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Arich Enterprise Co 5-Year Yield-on-Cost %?

Arich Enterprise Co ROCO:4173 -0.58% 67 5-Year Yield-on-Cost % is 12.52 as of Aug. 14, 2026, which is 102% above its 10-year median of 6.20. GuruFocus rates ROCO:4173 with a GF Score™ of 67/100 and a GF Value™ of NT$29.18 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Arich Enterprise Co ranks better than 93.84% on this metric.

Arich Enterprise Co's yield on cost for the quarter that ended in Mar. 2026 was 12.52.


The historical rank and industry rank for Arich Enterprise Co's 5-Year Yield-on-Cost % or its related term are showing as below:

ROCO:4173' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.42   Med: 6.2   Max: 15.9
Current: 12.52


During the past 13 years, Arich Enterprise Co's highest Yield on Cost was 15.90. The lowest was 2.42. And the median was 6.20.


ROCO:4173's 5-Year Yield-on-Cost % is ranked better than
93.84% of 276 companies
in the Healthcare Providers & Services industry
Industry Median: 2.91 vs ROCO:4173: 12.52

Arich Enterprise Co  (ROCO:4173) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Arich Enterprise Co 5-Year Yield-on-Cost % Related Terms


Arich Enterprise Co 5-Year Yield-on-Cost % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arich Enterprise Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Arich Enterprise Co's 5-Year Yield-on-Cost % falls into.


ROCO:4173
67GF Score
Arich Enterprise Co Ltd ROCO:4173
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arich Enterprise Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Arich Enterprise Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 12.52 mean?
Arich Enterprise Co (ROCO:4173) has a 5-Year Yield-on-Cost % of 12.52 as of Aug. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Arich Enterprise Co and its competitors. This is 102% above median its historical median of 6.20. Over the past decade, Arich Enterprise Co's 5-Year Yield-on-Cost % has ranged from 2.42 to 15.90. According to the industry distribution chart, Arich Enterprise Co ranks #17 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 6.2%.
Is Arich Enterprise Co's 5-Year Yield-on-Cost % too high?
Arich Enterprise Co's current 5-Year Yield-on-Cost % of 12.52 is 102% above median its 10-year median of 6.20. Over the past 10 years, this metric has ranged from a low of 2.42 to a high of 15.90. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.91. Arich Enterprise Co's value of 12.52 is 330.2% above this industry median. Based on the distribution chart, Arich Enterprise Co ranks #17 out of 276 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Arich Enterprise Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arich Enterprise Co's 5-Year Yield-on-Cost % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Arich Enterprise Co ranks #17 out of 276 companies for 5-Year Yield-on-Cost %. This places Arich Enterprise Co in the top 6% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.91. Arich Enterprise Co's value of 12.52 is 330.2% above this benchmark. Historically, Arich Enterprise Co's own 5-Year Yield-on-Cost % has ranged from 2.42 to 15.90 over the past decade. While the company's 10-year median is 6.20 vs. the industry median of 2.91, Arich Enterprise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.91, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arich Enterprise Co's current 5-Year Yield-on-Cost % of 12.52 is 330.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Arich Enterprise Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arich Enterprise Co's current 5-Year Yield-on-Cost % is 12.52, which is 102% above median its own 10-year median of 6.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arich Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Arich Enterprise Co (ROCO:4173) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.18, compared to a current price of NT$17.25 — trading 40.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 12.52, which is 102% above median its 10-year median of 6.20 and 330.2% above the Healthcare Providers & Services industry median of 2.91. Arich Enterprise Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Arich Enterprise Co (ROCO:4173), the current 5-Year Yield-on-Cost % is 12.52 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arich Enterprise Co (ROCO:4173) Overvalued in 2026?

Based on GuruFocus' analysis, Arich Enterprise Co stock appears to be undervalued. The current stock price of NT$17.25 is trading 40.9% below its estimated GF Value™ of NT$29.18. GuruFocus considers Arich Enterprise Co to be Possible Value Trap.

Key valuation signals for ROCO:4173:

  • 5-Year Yield-on-Cost %: 12.52 (102% above median its 10-year median of 6.20)
  • GF Value™: NT$29.18 vs. price of NT$17.25 (40.9% below fair value)
  • GF Score™: 67/100 with 4 warning signs
  • Industry Position: 330.2% above the Healthcare Providers & Services median (#17 of 276)

No single metric tells the full story. See the ROCO:4173 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arich Enterprise Co Business Description

Address No.880, Zhongzheng Road, 14th Floor-5, Zhonghe District, Taipei, TWN, 235601
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.
67GF Score

Get the complete analysis for ROCO:4173

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.25
Price
NT$29.18
GF Value